Skip to main content
. 2020 Nov 20;6(11):e05558. doi: 10.1016/j.heliyon.2020.e05558

Table 1.

A summary of the designed PLpro inhibitors (L1-L20).

Sl. No. Compd No. R IUPAC name Molecular Formula
1 L1 4-fluorophenyl 2-(4-fluorophenyl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C22H18FNO2
2 L2 4-fluoropyridin-2-yl 2-(4-fluoropyridin-2-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C21H17FN2O2
3 L3 2-fluoropyrimidin-4-yl 2-(2-fluoropyrimidin-4-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C20H16FN3O2
4 L4 4-fluoropiperidin-3-yl 2-(4-fluoropiperidin-3-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C21H23FN2O2
5 L5 2-fluoromorpholin-3-yl 2-(2-fluoromorpholin-3-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C20H21FN2O3
6 L6 4-fluoro-1H-pyrrol-3-yl 2-(4-fluoro-1H-pyrrol-3-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C20H17FN2O2
7 L7 2-fluoro-1H-imidazol-4-yl 2-(2-fluoro-1H-imidazol-4-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C19H16FN3O2
8 L8 4-fluorofuran-3-yl 2-(4-fluorofuran-3-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C20H16FNO3
9 L9 2-fluoro-1,3-oxazol-4-yl 2-(2-fluoro-1,3-oxazol-4-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C19H15FN2O3
10 L10 5-fluoro-1,3,4-oxadiazol-2-yl 2-(5-fluoro-1,3,4-oxadiazol-2-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C18H14FN3O3
11 L11 2-fluoro-2H-pyran 2′-fluoro-N-(naphthalen-1-yl)-3,4-dihydro-2H,2′H-[2,4′-bipyran]-4-carboxamide C21H18FNO3
12 L12 3-fluoro-1,4-dioxan-2-yl 2-(3-fluoro-1,4-dioxan-2-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C20H20FNO4
13 L13 2-fluoro-2,3-dihydro-1H-indol-6-yl 2-(2-fluoro-2,3-dihydro-1H-indol-6-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C24H21FN2O2
14 L14 4-fluoroquinolin-7-yl 2-(4-fluoroquinolin-7-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C25H19FN2O2
15 L15 4-fluoro-2H-1-benzopyran-7-yl 2-(4-fluoro-2H-1-benzopyran-7-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C25H20FNO3
16 L16 6-fluoro-9H-purin-2-yl 2-(6-fluoro-9H-purin-2-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C21H16FN5O2
17 L17 2-fluoro-1-benzofuran-5-yl 2-(2-fluoro-1-benzofuran-5-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C24H18FNO3
18 L18 2-fluoro-1H-benzimidazol-5-yl 2-(2-fluoro-1H-benzimidazol-5-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C23H18FN3O2
19 L19 2-fluoro-1,3-benzoxazol-6-yl 2-(2-fluoro-1,3-benzoxazol-6-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C23H17FN2O3
20 L20 3-fluoro-2-oxo-2H-1-benzopyran-6-yl 2-(3-fluoro-2-oxo-2H-1-benzopyran-6-yl)-N-(naphthalen-1-yl)-3,4-dihydro-2H-pyran-4-carboxamide C25H18FNO4